CDMO, API & small molecules, CRO, consulting & regulatory, logistics & packaging and more: the companies building biopharma outsourcing in Delhi, with their founders, funding, team size and business models.
Recent biopharma outsourcing business events in India
Funding, M&A, contract wins and launches involving 2,490 biopharma outsourcing companies in India, last 24 months: 82 M&A deals · 18 Contracts · 18 funding rounds · 3 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.
The Indian government has officially approved the acquisition of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL) by Skymap Pharmaceuticals Pvt Ltd for ₹121 crore.
Indoco Remedies has successfully completed the transfer of its ophthalmic business division to Sunways (India) Private Limited. This strategic move, finalised on May 18, 2026, involves…
DataM Intelligence has unveiled its latest report on the 'Synchronous Motors Market Size 2026' delivering powerful insights into key trends, future growth opportunities, and evolving…
Report
ContractSupply
Panacea biotec · client: Central Medical Services Society (CMSS)
Panacea Biotec has announced the receipt of a Letter of Award from the Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, Government of India. The…
Jubilant Ingrevia has successfully acquired a 100% equity stake in Remidex Pharma Private Limited.
Pharmaceutical
M&AMerger · Announced
EPL acquires Indovida India Private Limited
EPL Limited and Indovida India Private Limited have today signed definitive agreements for a merger. The combined platform will have a valuation of ~$2 billion.
SteinCares, a specialty healthcare company in Latin America, entered into a strategic licensing agreement with Shilpa Biologicals Pvt. Ltd.
Healthcare
M&AAcquisition · Rumored
Consortium led by Warburg Pincus and Mubadala acquires Encube ethicals
Separately, a consortium led by Warburg Pincus and Abu Dhabi-based sovereign investor Mubadala is in advanced talks to buy a majority stake in contract manufacturer Encube Ethicals, ET…
Separately, a consortium led by Warburg Pincus and Abu Dhabi-based sovereign investor Mubadala is in advanced talks to buy a majority stake in contract manufacturer Encube Ethicals
New Delhi: Eris Lifesciences Limited has completed the acquisition of the remaining 30 percent stake in Swiss Parenterals Limited, making it a wholly owned subsidiary
Two Jubilant Bhartia Group subsidiaries raised a combined 56.50 billion rupees through zero-coupon bonds in June to fund the acquisition of a 40% stake in Hindustan Coca-Cola Holdings.
Aurobindo Pharma, a wholly owned subsidiary of Aurobindo Pharma, at its meeting held on Monday, i.e., January 1, 2026, has approved the acquisition of the non-oncology prescription…
Pharmaceuticals
M&AAcquisition · Completed
Cactus acquires Baker Hughes Company’s Surface Pressure Control business
Cactus, Inc. today announced the completion of the acquisition of a majority interest in Baker Hughes Company’s Surface Pressure Control business.
Aurobindo Pharma Ltd said its wholly owned arm, Auro Pharma Ltd, has acquired the branded non-oncology prescription formulations business of Khandelwal Laboratories Private Ltd on a…
Piramal Pharma Limited (PPL) has entered into an agreement to acquire a 100% stake in Hemmo Pharmaceuticals Pvt. Ltd., an Indian manufacturer of synthetic peptide APIs (active…
Earlier in October, UNICEF also placed a significant order for polio vaccines. Panacea Biotec received the letter of award (LoA) as part of a long-term agreement to supply bOPV in 10 and…
Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor to Eris Lifesciences Limited (“ELL”) in connection with its proposed acquisition of 30% of the total share capital of…
The National Company Law Tribunal (NCLT) has approved the merger of SeQuent Scientific, a leading player in the global animal health industry, and Viyash Lifesciences, an integrated…
ANG Lifesciences India, a fast-growing organisation with an ultra-modern fully integrated, manufacturing facility dedicated to dry powder injectables (SVP), has acquired the printing and…
Global private equity firms Advent International and Warburg Pincus have joined the race for a stake purchase in contract drug maker Encube Ethicals Pvt. Ltd.
Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor for an on-market sale of 8.93% shareholding in Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited)…
SAM also advised on the subsequent merger of Cohance with and into Suven, upon which Suven was renamed as Cohance.
Biopharma outsourcing companies in Delhi, by revenue
Browse biopharma outsourcing companies in Delhi by reported revenue, one-year revenue growth, revenue model, age and stage. The 50 companies below are the largest by their most recent reported revenue among 66 biopharma outsourcing companies in Delhi that have filed a figure in the last four years. Every figure keeps its own reporting period, so compare periods before comparing amounts.
Showing 25 of 50
Company & businessRevenueRevenue growthHeadcount & growthAgeJobs · last 3 months
CDMO focusing on spectrum of dosage forms and therapeutic segments
Every company, not just 50All 132 biopharma outsourcing companies in Delhi, filterable by stage, funding, team size, revenue model and age.
Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
Save and exportBuild lists, compare companies side by side and export them from your Radar account.
Explore biopharma outsourcing companies in Delhi by what you are looking for
Browse top biopharma outsourcing companies in Delhi, including CDMOs, API manufacturers and clinical research providers. You can also find biopharma outsourcing startups in Delhi and see which companies are hiring.
8 ways to explore biopharma outsourcing in Delhi
CDMO & pharma contract manufacturing companiesAPI & small molecule drug manufacturersClinical research (CRO) & development servicesPharma consulting & market research servicesPharma logistics & packaging providersListed biopharma outsourcing companies in Delhi
CDMO & pharma contract manufacturing companies
Contract development and manufacturing organisations producing formulations and dosage forms.
Akums
CDMO focusing on spectrum of dosage forms and therapeutic segments
Supplier of API offering a range of nicotine products, including vegetable glycerine, nicotine alkaloids, synthetic nicotine, and nicotine dilutions, catering to the pharmaceutical industry
Revenue, profit and growth from the filed annual accounts of 72 biopharma outsourcing companies in Delhi for FY24-25 — 79 of the 132 companies on this page file accounts with the Ministry of Corporate Affairs. The five largest earn 47% of the revenue, so medians describe the typical company better than totals.
combined revenue, FY24-25₹5,711.79 cr
72 companies filing accounts
combined net profit₹413.91 cr
7.2% aggregate margin
are profitable86%
62 of 72 companies
median revenue~₹19.6 cr
the typical company
median revenue growth+6%
into FY24-25
earned by the top five47%
revenue concentration
Six-year view
Combined revenue of filing companies
₹3,559.07 crFY19-2068 filers
₹3,940.09 crFY20-2173 filers
₹5,091.41 crFY21-2271 filers
₹5,522.59 crFY22-2371 filers
₹5,966.55 crFY23-2471 filers
₹5,711.79 crFY24-2572 filers
The number of companies filing changes each year; the three-year cohort below compares like with like.
Like-for-like
The same 67 companies over three years
+11%
FY22-23₹5,099.56 cr₹309.85 cr net
FY23-24₹5,496.51 cr₹10.61 cr net
FY24-25₹5,654.59 cr₹416.21 cr net
Companies with accounts for all three years, so growth is not an artefact of who filed.
Scale and profit
Bigger companies are far more often profitable
Under ₹1 cr650% profitable
₹1–10 cr1979% profitable
₹10–100 cr3190% profitable
₹100–1,000 cr15100% profitable
Over ₹1,000 cr1100% profitable
Companies by FY24-25 revenue. Bars show how many companies sit in each band.
Momentum
How fast revenue moved into FY24-25
Shrinking23
0–20%25
20–50%13
50–100%6
Doubled+2
69 companies with accounts for both years; median growth +6%.
Profitability
Profit is concentrated at the top
62profitable
10loss-making
7.2%aggregate margin
3.0%median margin
The aggregate margin is pulled up by a few large filers; the median shows the typical company.
Growth leaders · ₹10 cr+ revenue
Fastest growing, FY24-25
Company
Growth
Revenue
Glee BiotechGLEE BIOTECH LIMITED
Unistar BiotechUNISTAR BIOTECH LIMITED
APCO PharmaAPCO PHARMA LIMITED
Dhiti Life SciencesDHITI LIFE SCIENCES PRIVATE LIMITED
Narang BiotecNARANG BIOTEC PRIVATE LIMITED
+52%
₹138.01 cr
Medicamen OrganicsMedicamen Organics Limited.
Profit leaders · ₹10 cr+ revenue
Highest net margins, FY24-25
Company
Margin
Revenue
ImmuneticIMMUNETIC LIFESCIENCES PRIVATE LIMITED
27.0%
₹13.68 cr
Coral DrugsCORAL DRUGS PRIVATE LIMITED
24.7%
₹126.90 cr
JagsonpalJAGSON PAL PHARMACEUTICALS LIMITED.
20.0%
₹276.91 cr
Jocund IndiaJOCUND INDIA LIMITED
Cooper PharmaCOOPER PHARMA LIMITED
Glee BiotechGLEE BIOTECH LIMITED
Inside the industry
Sub-sectors compared, FY24-25
Sub-sector
Companies
Revenue
Median revenue
Profitable
Margin
Biopharma outsourcing
65
₹5,094.34 cr
~₹18.8 cr
85%
7.7%
Leaders
Largest biopharma outsourcing companies by revenue, FY24-25
Standalone annual accounts filed with the Ministry of Corporate Affairs. Brands that share one legal entity are shown together and counted once.
Industry landscape report
AdTech Industry Landscape of Delhi
The financials above are one chapter. The full biopharma outsourcing landscape of Delhi maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
The figures on this page come from Fliar’s company, funding and MCA filings data. Use it through the Investor Intelligence API and MCA financials feeds, or explore every company, filing and investor in Radar.
Capital & corporate activity
Biopharma outsourcing funding and M&A across India
193 recorded equity rounds have gone to 2,490 biopharma outsourcing companies in India — how much, at which stage, into which sub-sectors, from whom, and how Delhi compares. Debt, IPO and grant rounds are excluded.
equity rounds, last 12 months2
US$270.00m
equity rounds, last 24 months7
US$425.09m
raised over five yearsUS$1.28bn
51 rounds in India
M&A deals, India82
last 24 months
Capital by year
Equity funding into biopharma outsourcing in India
amount rounds
$84m201811
$134m20199
$62m202011
$435m202116
$315m202214
$90m20238
$19m20246
$155m20256
$270m20261
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$435.16m across 16 rounds.
The funding ladder · five years
Rounds and typical cheque by stage
AngelUS$119.62m12 rounds · median US$500k
SeedUS$14.38m11 rounds · median US$1.29m
Series AUS$80.53m9 rounds · median US$4.40m
Series BUS$106.78m7 rounds · median US$16.27m
Series CUS$255.00m3 rounds · median US$80.00m
Series D+US$284.18m2 rounds · median US$142.09m
Private equityUS$423.40m7 rounds · median US$68.00m
Meet the people behind biopharma outsourcing companies in Delhi. 48 of 132 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Fastest revenue growth
Biopharma outsourcing companies in Delhi with the highest one-year revenue growth among those reporting at least ₹5 crore in revenue. Growth is the reported one-year change for the period shown.
Biopharma outsourcing
Pharmaceutical manufacturer that develops and manufactures a range of pharmaceutical products, including generic medications and branded formulations
Revenue growth · 2024–2025Revenue · FY 2024-25
Founders
Details not available
Biopharma outsourcing
Healthcare and wellness company providing technical and scientific support to global biotech companies
Revenue growth · 2024–2025Revenue · FY 2024-25
Leadership · 1
MJ
Manu JaggiCEO
Biopharma outsourcing
Pharmaceutical company that focuses on developing and marketing products for various therapeutic segments
Revenue growth · 2024–2025Revenue · FY 2024-25
Founders
Details not available
Biopharma outsourcing
Manufacturer of pharmaceutical products including nutraceuticals, sports nutrition, and ayurvedic items
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Recently founded
Biopharma outsourcing companies in Delhi founded in the last four years, newest first.
Biopharma outsourcing
Provider of pharmacovigilance technology and business process transformation consulting services
Founded2025Unfunded
Founders
Details not available
Biopharma outsourcing
Provider of site management services for clinical trials and research
Founded2024Unfunded
Founders
Details not available
Biopharma outsourcing
Contract manufacturer of health, wellness, personal care, and food nutrition products.
Founded2024Unfunded
Founders
Details not available
Biopharma outsourcing
Pharmaceutical exporting company that manufactures and supplies a range of products, including pharmaceuticals, medical disposables, vaccines, and APIs
Founded2024Unfunded
Founders
Details not available
Biopharma outsourcing
Manufacturer of pharmaceutical, nutraceutical, and ayurvedic medicines, offering contract services
Founded2024Unfunded
Founders
Details not available
Biopharma outsourcing
Pharmaceutical regulatory service provider offering expertise and consulting services
Founded2023Unfunded
Founders
Details not available
Biopharma outsourcing
Provider of consulting services for biopharma sector
Founded2023Unfunded
Founders
Details not available
Biopharma outsourcing
Supplier of API offering a range of nicotine products, including vegetable glycerine, nicotine alkaloids, synthetic nicotine, and nicotine dilutions, catering to the pharmaceutical industry
Founded2022Unfunded
Founders
Details not available
Biopharma outsourcing
Provider of skill development and learning training in BioIT and biotechnology
Founded2022Unfunded
Founders
Details not available
Biopharma outsourcing
Manufacturer of oral nicotine pouches, disposable vaping products, and energy pouches
Founded2022Unfunded
Founders
Details not available
Biopharma outsourcing
Manufacturer of health supplements offering contract and private label manufacturing
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore Delhi biopharma outsourcing companies by sub-sector
The most common specialisations among biopharma outsourcing companies in Delhi. Open a company to see what it sells, who runs it and how far it has come.
Traditional pharmaceuticals · 6
6 biopharma outsourcing companies in Delhi work in traditional pharmaceuticals. Shown: the best-documented.
We will reply with coverage, fields and pricing for your use case.
Radar members
Log in to see every figure
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.